Skip to main content
Fig. 2 | Microbiome

Fig. 2

From: Metabolite-based dietary supplementation in human type 1 diabetes is associated with microbiota and immune modulation

Fig. 2

Increased concentration of short-chain fatty acids in stool and plasma following HAMSAB supplementation. A Acetate, propionate, and butyrate concentrations in stool (mM) and B plasma (μM). Overall significance determined by GEE and pairwise differences between timepoints by estimated marginal means and include a Tukey adjustment for multiple corrections. Colors indicate individual subjects. Box plots show mean and upper and lower quartile ranges

Back to article page

Microbiome

ISSN: 2049-2618

Contact us